ArticlePloS one2026
Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOut-of-pocket (OOP) payments are a common component of healthcare financing in many low-and middle-income countries including Ghana. Despite implementation of the National Health Insurance Scheme in Ghana which is expected to protect against catastrophic OOP payments, patients still make some form of payments with its attendant negative implications for improved health status. We examined the prevalence and self-reported effects of OOP payments among hypertensive patients insured under the National Health Insurance Scheme attending a referral hospital in Hohoe, Ghana.
methodsThis was a cross-sectional study conducted among 389 hypertensive patients between February and May 2022 using a structured questionnaire. Data collected were analysed using Stata software version 15. We employed descriptive statistics and logistic regression in analysing the data. Statistical significance was considered at p < 0.05.
resultsA total of 97.2% respondents made OOP payments in receiving healthcare with 97.1% of those who made such payments having made them at the point of receiving drugs. Difficulty in making OOP payments was reported by 29.1% of the respondents and this was associated with ever borrowing money to cover health expense (aOR=2.52; 95% CI: 1.31-4.88; p = 0.006), OOP payments affecting hospital attendance (aOR=5.52; 95% CI: 2.74-11.11; p < 0.001) and having an alternative form of treating hypertension (aOR=2.93; 95% CI: 1.60-5.38; p = 0.001).
conclusionOOP payments are widespread in the utilisation of healthcare for hypertensive patients. This raises concerns about progress towards the attainment of Sustainable Development Goals (SDGs) 3.4 which seeks to control non-communicable diseases and SDG 3.8 which seeks to ensure universal health coverage. Medications or drugs are the major healthcare services for which individual hypertensive patients made OOP payments thus highlighting the need ensure availability and accessibility of drugs to meet the global targets of SDG 3 and due to the long-term treatment requirements of hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.